Citations

Clear

3314 citation(s) found for "Do, Alexander".

Research using the Quality Outcomes Database: accomplishments and future steps toward higher-quality real-world evidence
Asher, Anthony L. , Haid, Regis W., Stroink, Ann R., Michalopoulos, Giorgos D. , Alexander, A. Yohan , Zeitouni, Daniel , Chan, Andrew K. , Virk, Michael S., Glassman, Steven D. , Foley, Kevin T. , Slotkin, Jonathan R., Potts, Eric A. , Shaffrey, Mark E., Shaffrey, Christopher I. , Upadhyaya, Cheerag D., Coric, Domagoj , Tumialán, Luis M. , Chou, Dean , Fu, Kai-Ming, Knightly, John J. , Orrico, Katie O., Wang, Michael Y. , Bisson, Erica F. , Mummaneni, Praveen V. , Bydon, Mohamad , Michalopoulos, Giorgos , Alexander, A Yohan , Virk, Michael S., Park, Paul

Mayo Clinic

Journal of Neurosurgery | May 20, 2023 | Volume: 139 | Issue: 6 | Pages: 1757-1775

10.3171/2023.3.jns222601 | PMID 37209070 Get It

OBJECTIVE The Quality Outcomes Database (QOD) was established in 2012 by the NeuroPoint Alliance, a nonprofit organization supported by the American Association of Neurological Surgeons. Currently, the QOD has launched six different modules to cover a broad spectrum of neurosurgical practice—namely lumbar spine surgery, cervical spine surgery, brain tumor, stereotactic radiosurgery (SRS), functional neurosurgery for Parkinson’s disease, and cerebrovascular surgery. This investigation aims to summarize research efforts and evidence yielded through QOD research endeavors. METHODS The authors identified all publications from January 1, 2012, to February 18, 2023, that were produced by using data collected prospectively in a QOD module without a prespecified research purpose in the context of quality surveillance and improvement. Citations were compiled and presented along with comprehensive documentation of the main study objective and take-home message. RESULTS A total of 94 studies have been produced through QOD efforts during the past decade. QOD-derived literature has been predominantly dedicated to spinal surgical outcomes, with 59 and 22 studies focusing on lumbar and cervical spine surgery, respectively, and 6 studies focusing on both. More specifically, the QOD Study Group—a research collaborative between 16 high-enrolling sites—has yielded 24 studies on lumbar grade 1 spondylolisthesis and 13 studies on cervical spondylotic myelopathy, using two focused data sets with high data accuracy and long-term follow-up. The more recent neuro-oncological QOD efforts, i.e., the Tumor QOD and the SRS Quality Registry, have contributed 5 studies, providing insights into the real-world neuro-oncological practice and the role of patient-reported outcomes. CONCLUSIONS Prospective quality registries are an important resource for observational research, yielding clinical evidence to guide decision-making across neurosurgical subspecialties. Future directions of the QOD efforts include the development of research efforts within the neuro-oncological registries and the American Spine Registry—which has now replaced the inactive spinal modules of the QOD—and the focused research on high-grade lumbar spondylolisthesis and cervical radiculopathy.
Through-the-scope suture closure of nonampullary duodenal endoscopic mucosal resection defects: a retrospective multicenter cohort study
Almario, Jose Antonio , Zhang, Linda Y. , Cohen, Jonathan , Haber, Gregory , Ramberan, Hemchand, Gordon, Stuart R. , Adler, Jeffrey M., Pohl, Heiko , Schlachterman, Alexander , Qumseya, Bashar , Kumta, Nikhil A. , Kim, Raymond , Aihara, Hiroyuki , Shrigiriwar, Apurva , Ngamruengphong, Saowanee , Khashab, Mouen A., group, Working, Storm, Andrew C , Canakis, Andrew , Storm, Andrew C. , Kumar, Anand , Singh, Shailendra , Draganov, Peter V. , Canakis, Andrew , Khashab, Mouen A. , group, Working

Mayo Clinic

Endoscopy | May 19, 2023 | Volume: 55 | Issue: 09 | Pages: 865-870

10.1055/a-2077-4832 | PMID 37207666 Get It

Background Delayed bleeding is among the most common adverse events associated with endoscopic mucosal resection (EMR) of nonampullary duodenal polyps. We evaluated the rate of delayed bleeding and complete defect closure using a novel through-the-scope (TTS) suturing system for the closure of duodenal EMR defects. Methods We reviewed the electronic medical records of patients who underwent EMR for nonampullary duodenal polyps of ≥ 10 mm and prophylactic defect closure with TTS suturing between March 2021 and May 2022 at centers in the USA. We evaluated the rates of delayed bleeding and complete defect closure. Results 36 nonconsecutive patients (61 % women; mean [SD] age, 65 [12] years) underwent EMR of ≥ 10-mm duodenal polyps followed by attempted defect closure with TTS suturing. The mean (SD) lesion size was 29 (19) mm, defect size was 37 (25) mm; eight polyps (22 %) involved > 50 % of the lumen circumference. Complete closure was achieved in all cases (78 % with TTS suturing alone), using a median of one TTS suturing kit. There were no cases of delayed bleeding and no adverse events attributed to application of the TTS suturing device. Conclusion Prophylactic closure of nonampullary duodenal EMR defects using TTS suturing resulted in a high rate of complete closure and no delayed bleeding events.
59. The Effect of Local Exosomes, Stem Cells and Tacrolimus on Neurite Extension
Saffari, Tara Sara, Rademakers, Daan J., Saffari, Tiam M. , Shin, Alexander Y.

Mayo Clinic

Plastic and Reconstructive Surgery - Global Open | May 18, 2023 | Volume: 11 | Issue: 5S | Pages: 37-37

10.1097/01.gox.0000937828.37390.7d Get It

Sex differences in the intensity–duration relationships of the severe‐ and extreme‐intensity exercise domains
Alexander, Andrew M. , Hurla, Logan M., Didier, Kaylin D. , Hammer, Shane M. , Rollins, Korynne S. , Barstow, Thomas J.

Mayo Clinic

European Journal of Sport Science | May 18, 2023 | Volume: 23 | Issue: 11 | Pages: 2221-2231

10.1080/17461391.2023.2215723 | PMID 37199235 Get It

ABSTRACTExtreme‐intensity exercise is described by W′ext (analogous to J′ for isometric exercise) that is smaller than W′ of severe‐intensity exercise (W′sev) in males. Sex differences in exercise tolerance appear to diminish at near‐maximal exercise, however, there is evidence of greater contributions of peripheral fatigue (i.e. potentiated twitch force; Qpot) in males during extreme‐intensity exercise. Therefore, the current study tested the hypotheses that J′ext would not be different between males and females, however, males would exhibit a greater reduction in neuromuscular function (i.e. maximal voluntary contraction, MVC; Qpot) following extreme‐intensity exercise. Seven males and 7 females completed three severe‐ (Tlim: 2–4 min, S3; 5–8 min, S2; 9–15 min, S1) and three extreme‐intensity (70, 80, 90%MVC) knee‐extension bouts. MVC and Qpot relative to baseline were compared at task failure and at 150 s of recovery. J′ext was significantly less than J′sev in males (2.4 ± 1.2kJ vs 3.9 ± 1.3kJ; p = 0.03) and females (1.6 ± 0.8kJ vs 2.9 ± 1.7kJ; p = 0.05); however, there were no sex differences in J′ext or J′sev. MVC (%Baseline) was greater at task failure following extreme‐intensity exercise (76.5 ± 20.0% vs 51.5 ± 11.5% in males, 75.7 ± 19.4% vs 66.7 ± 17.4% in females), but was not different at 150 s of recovery (95.7 ± 11.8% in males, 91.1 ± 14.2% in females). Reduction in Qpot, however, was greater in males (51.9 ± 16.3% vs 60.6 ± 15.5%) and was significantly correlated with J′ext (r2 = 0.90, p < 0.001). Although there were no differences in the magnitude of J′ext, differences in MVC and Qpot are evidence of sex‐specific responses and highlight the importance of appropriately characterizing exercise intensity regarding exercise domains when comparing physiological responses in males and females.Highlights We have previously shown evidence that extreme‐intensity dynamic exercise is described by W′ext in males and smaller than W′sev. We currently tested for potential sex differences in J′ext (isometric analogue to W′) and neuromuscular responses (i.e. maximal voluntary contraction, MVC; potentiated twitch force, Qpot) during extreme‐intensity exercise. J′ext and extreme‐intensity exercise tolerance was not different between males and females. The reduction in MVC was not different across extreme‐intensity exercise across males and females, whereas the reduction in Qpot was greater in males following all extreme‐intensity exercises, although not after exercise at 90%MVC. Together, although extreme‐intensity exercise tolerance is not different, these data highlight differences in the contributing mechanisms of fatigue during severe‐ and extreme‐intensity exercise between males and females.
The Alzheimer's Disease Prediction Of Longitudinal Evolution (TADPOLE) Challenge: Results after 1 Year Follow-up
Bron, Esther E. , Toga, Arthur W. , Weiner, Michael W. , Barkhof, Frederik , Fox, Nick C. , Eshaghi, Arman , Toni, Tina, Salaterski, Marcin, Lunina, Veronika, Ansart, Manon , Lu, Pascal , Thompson, Wesley K., Nahon, Aviv, Levy, Yarden, Halbersberg, Dan, Cohen, Mariya, Liao, Huiling , Yu, Kaixian , Ismail, Aya, Wood, Timothy C. , Nguyen, Minh , Sun, Nanbo , Yeo, B.T. Thomas , Qi, Ke , Chen, Shiyang , Qiu, Deqiang , Buciuman, Ionut, Kelner, Alex, Rimocea, Denisa, Ourselin, Sébastien , Venkatraghavan, Vikram , Liu, Keli , Rabe, Christina, Manser, Paul T. , Howlett, James , Huang, Zhiyue , Mukherjee, Sach, Rouanet, Anaïs , Oriol, Javier de Velasco , Clemente, Edgar E. V., Estrada, Karol , Altmann, André , Stonnington, Cynthia M. , Wu, Jianfeng , Devadas, Vivek, Fourrier, Clémentine , Doshi, Jimit , Moore, Paul J. , Lyons, Terry , Ciszek, Robert, Jedynak, Bruno , Pandya, K., Engels, William R., Cole, Joseph B., Golland, Polina , Alexander, Daniel C. , Initiative, The Alzheimer's Disease Neuroimaging, Toga, Arthur W , Barkhof, Frederik , Fox, Nick C , Weiner, Michael W , Marinescu, Razvan Valentin , Oxtoby, Neil P. , Young, Alexandra L. , Durrleman, Stanley , Iddi, Samuel , Li, Dan , Donohue, Michael , Li, Tengfei , Zhu, Hongtu , Tamez‐Peña, José G. , Wood, Timothy, Bravo, Héctor Corrada , Feng, Jiashi , Chen, Gang , Qi, Ke, Pop, Raluca, Ghazi, Mostafa Mehdipour , Nielsen, Mads , Sørensen, Lauge , Hill, Steven M., Kiddle, Steven John , Taschler, Bernd , Tom, Brian D. M. , White, Simon Richard , Faux, Noel Garry , Sedai, Suman , Aksman, Leon , Wang, Yalin , Rakêt, Lars Lau , Sotiras, Aristeidis , Erus, Güray , Davatzikos, Christos , Vogel, Jacob W. , Doyle, Andrew , Tam, Angela , Diaz-Papkovich, Alex , Jammeh, Emmanuel , Koval, Igor , Gallacher, John , Tohka, Jussi , Pandya, Kruti, Bilgel, Murat , Engels, William, Cole, Joseph, Klein, Stefan , Initiative, The Alzheimer's Disease Neuroimaging

Mayo Clinic

Machine Learning for Biomedical Imaging | May 17, 2023 | Volume: 1 | Issue: December 2021 | Pages: 1-60

10.59275/j.melba.2021-2dcc Get It

Accurate prediction of progression in subjects at risk of Alzheimer's disease is crucial for enrolling the right subjects in clinical trials. However, a prospective comparison of state-of-the-art algorithms for predicting disease onset and progression is currently lacking. We present the findings of "The Alzheimer's Disease Prediction Of Longitudinal Evolution" (TADPOLE) Challenge, which compared the performance of 92 algorithms from 33 international teams at predicting the future trajectory of 219 individuals at risk of Alzheimer's disease. Challenge participants were required to make a prediction, for each month of a 5-year future time period, of three key outcomes: clinical diagnosis, Alzheimer's Disease Assessment Scale Cognitive Subdomain (ADAS-Cog13), and total volume of the ventricles. The methods used by challenge participants included multivariate linear regression, machine learning methods such as support vector machines and deep neural networks, as well as disease progression models. No single submission was best at predicting all three outcomes. For clinical diagnosis and ventricle volume prediction, the best algorithms strongly outperform simple baselines in predictive ability. However, for ADAS-Cog13 no single submitted prediction method was significantly better than random guesswork. Two ensemble methods based on taking the mean and median over all predictions, obtained top scores on almost all tasks. Better than average performance at diagnosis prediction was generally associated with the additional inclusion of features from cerebrospinal fluid (CSF) samples and diffusion tensor imaging (DTI). On the other hand, better performance at ventricle volume prediction was associated with inclusion of summary statistics, such as the slope or maxima/minima of patient-specific biomarkers. On a limited, cross-sectional subset of the data emulating clinical trials, performance of the best algorithms at predicting clinical diagnosis decreased only slightly (2 percentage points) compared to the full longitudinal dataset. The submission system remains open via the website https://tadpole.grand-challenge.org, while TADPOLE SHARE (https://tadpole-share.github.io/) collates code for submissions. TADPOLE's unique results suggest that current prediction algorithms provide sufficient accuracy to exploit biomarkers related to clinical diagnosis and ventricle volume, for cohort refinement in clinical trials for Alzheimer's disease. However, results call into question the usage of cognitive test scores for patient selection and as a primary endpoint in clinical trials.
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
Zarif, Talal El , Nassar, Amin H. , Adib, Elio , Fitzgerald, Bailey G. , Huang, Jiaming , Mouhieddine, Tarek H. , Rubinstein, P , Nonato, Taylor K., McKay, Rana R. , Li, Mingjia , Baiocchi, Robert A. , Lorentsen, Michael , Dittus, Christopher , Dizman, Nazlı , Falohun, Adewunmi, Abdel‐Wahab, Noha , Diab, Adi , Bankapur, Anand, Reed, Alexandra, Kim, Chul , Arora, Aakriti, El‐Am, Edward , Abdallah, Wassim , Al‐Hader, Ahmad, Ghazal, Batool Abu, Drolen, Claire , Drakaki, Alexandra , Baena, Javier , Nebhan, Caroline A. , Haykal, Tarek , Morse, Michael A. , Cortellini, Alessio , Pinato, David J. , Pria, Alessia Dalla , Bakalov, Veli , Bahary, Nathan , Rajkumar, Aarthi , Mangla, Ankit , Singh, Parminder , Nana, Frank Aboubakar , Lopetegui‐Lia, Nerea , Dobbs, Ryan W. , Funchain, Pauline , Long, Georgina V. , Genova, Carlo , Barletta, Giulia, Idossa, Damé , Lamberti, Giuseppe , Freeman, Dory , Chiao, Elizabeth Y. , Johnson, Douglas B. , Ramaswami, Ramya , Bower, Mark , Emu, Brinda , Baden, Lindsey R. , Sonpavde, Guru , Naqash, Abdul Rafeh , El Zarif, Talal , Rubinstein, Paul G , Mittra, Arjun , Owen, Dwight H , Lorentsen, Michael , Dittus, Christopher , Dizman, Nazli , Abdel-Wahab, Noha , Diab, Adi , Kim, Chul , Shah, Neil J , Kozaily, Elie , Abdallah, Wassim , Saeed, Anwaar , Drolen, Claire , Lechner, Melissa G , Drakaki, Alexandra , Nebhan, Caroline A , Haykal, Tarek , Cortellini, Alessio , Pinato, David J , Dalla Pria, Alessia , Hall, Evan , Bahary, Nathan , Mangla, Ankit , Shah, Vishal , Aboubakar Nana, Frank , Lopetegui-Lia, Nerea , Dima, Danai , Dobbs, Ryan W , Funchain, Pauline , Woodford, Rachel , Long, Georgina V , Menzies, Alexander M , Genova, Carlo , Puri, Sonam , Florou, Vaia , Lamberti, Giuseppe , Addeo, Alfredo , Bersanelli, Melissa , Xie, Wanling , Reid, Erin G , Chiao, Elizabeth Y , Sharon, Elad , Johnson, Douglas B , Ramaswami, Ramya , Bower, Mark , Choueiri, Toni K , Lurain, Kathryn , Sonpavde, Guru , Naqash, Abdul Rafeh , Nassar, Amin H. , Singh, Parminder , Saeed, Anwaar , Shah, Vishal , Dima, Danai , Saleem, Rabia, Saponara, Maristella , Queirolo, Paola , Addeo, Alfredo , Xie, Wanling , Sharon, Elad , Marron, Thomas , Choueiri, Toni K. , Espinar, Javier Baena

Mayo Clinic

Journal of Clinical Oncology | May 16, 2023 | Volume: 41 | Issue: 21 | Pages: 3712-3723

10.1200/jco.22.02459 | PMID 37192435 Get It

PURPOSE Compared with people living without HIV (PWOH), people living with HIV (PWH) and cancer have traditionally been excluded from immune checkpoint inhibitor (ICI) trials. Furthermore, there is a paucity of real-world data on the use of ICIs in PWH and cancer. METHODS This retrospective study included PWH treated with anti–PD-1- or anti–PD-L1-based therapies for advanced cancers. Kaplan-Meier method was used to estimate overall survival (OS) and progression-free survival (PFS). Objective response rates (ORRs) were measured per RECIST 1.1 or other tumor-specific criteria, whenever feasible. Restricted mean survival time (RMST) was used to compare OS and PFS between matched PWH and PWOH with metastatic NSCLC (mNSCLC). RESULTS Among 390 PWH, median age was 58 years, 85% (n = 331) were males, 36% (n = 138) were Black; 70% (n = 274) received anti–PD-1/anti–PD-L1 monotherapy. Most common cancers were NSCLC (28%, n = 111), hepatocellular carcinoma ([HCC]; 11%, n = 44), and head and neck squamous cell carcinoma (HNSCC; 10%, n = 39). Seventy percent (152/216) had CD4+ T cell counts ≥200 cells/µL, and 94% (179/190) had HIV viral load <400 copies/mL. Twenty percent (79/390) had any grade immune-related adverse events (irAEs) and 7.7% (30/390) had grade ≥3 irAEs. ORRs were 69% (nonmelanoma skin cancer), 31% (NSCLC), 16% (HCC), and 11% (HNSCC). In the matched mNSCLC cohort (61 PWH v 110 PWOH), 20% (12/61) PWH and 22% (24/110) PWOH had irAEs. Adjusted 42-month RMST difference was –0.06 months (95% CI, –5.49 to 5.37; P = .98) for PFS and 2.23 months (95% CI, –4.02 to 8.48; P = .48) for OS. CONCLUSION Among PWH, ICIs demonstrated differential activity across cancer types with no excess toxicity. Safety and activity of ICIs were similar between matched cohorts of PWH and PWOH with mNSCLC.
Correlation Between Fontan Pathway Diameter and Inferior-Superior Vena Cava Gradients in Adults Undergoing Exercise Catheterization
Miranda, William R. , Jain, C. Charles , Hagler, Donald J. , Connolly, Heidi M. , Egbe, Alexander C. , Cabalka, Allison K. , Hagler, Donald J , François, Christopher J. , Connolly, Heidi M , Egbe, Alexander C , Burchill, Luke J.

Mayo Clinic

Circulation: Cardiovascular Interventions | May 16, 2023 | Volume: 16 | Issue: 5 | Pages: No page available

10.1161/circinterventions.122.012493 | PMID 37192313 Get It

The Spectrum of Duodenal Histologic Findings in Patients With Trisomy 21
Alexander, Erin , Stahl, Marisa G. , Weaver, Amy L. , Devara, Janaki , Fahey, Lisa M. , Singh, Arunjot , Leonard, Maureen M. , Weisbrod, Vanessa , Shull, Mary , Silvester, Jocelyn A. , Kramer, Zachary , Kerzner, Benny, Liu, Edwin , Absah, Imad , Silvester, Jocelyn A , Weisbrod, Vanessa

Mayo Clinic

Journal of Pediatric Gastroenterology and Nutrition | May 15, 2023 | Volume: 77 | Issue: 2 | Pages: 184-190

10.1097/mpg.0000000000003825 | PMID 37184455 Get It

Objectives:Patients with Trisomy 21 (T21) commonly have gastrointestinal symptoms and diseases that prompt evaluation with esophagogastroduodenoscopy (EGD). Our objective is to characterize duodenal histological abnormalities in these patients when undergoing EGD. A secondary aim is to explore associations of histologic findings with different therapies.Methods:Patients 30 years old or younger with T21 who underwent EGD from 2000 to 2020 at 6 hospitals were included in this retrospective cohort study. Duodenal biopsies were categorized based on reported histopathology findings as normal or abnormal. Abnormal pathology reports were reviewed and categorized into villous atrophy (VA) and duodenitis without VA. The VA group was further categorized based on the presence or absence of celiac disease (CD).Results:We identified 836 patients with T21 who underwent EGD, 419 (50.1%) of whom had duodenal histologic abnormalities. At the time of the first (index) abnormal duodenal biopsy, 290 of 419 had VA and of those, 172 of 290 met CD diagnostic criteria, while 118 of 290 did not meet CD criteria (nonspecific VA). Among the patients with an abnormal biopsy, acid suppression at the time of the index biopsy was less common in patients with VA‐CD compared to patients without VA or patients with nonspecific VA (12.2% vs 45.7% vs 44.9%).Conclusions:Half of the T21 patients in this cohort had abnormal duodenal biopsies including a subgroup with nonspecific VA. In this cohort, acid suppression use was more prevalent in patients with abnormalities other than CD.
Pre-hematopoietic stem cell transplantation lung computed tomography is not an alternative to PFT for pediatric patients with sickle cell disease
Ngwube, Alexander , Ritchey, Andrew , Mirea, Lucia , Williams, Sophia , Adams, Roberta H. , Mirea, Lucia , Adams, Roberta, Garcia, Angela

Mayo Clinic

Pediatric Hematology and Oncology | May 11, 2023 | Volume: 40 | Issue: 7 | Pages: 696-700

10.1080/08880018.2023.2186554 | PMID 37166203 Get It

Introduction to the COG Diagnostic Imaging Committee/SPR Oncology Committee White Papers: Rationale and methods
Tang, Elizabeth , Alazraki, Adina , Thacker, Paul G. , McCarville, M. Beth , Towbin, Alexander J. , Alazraki, Adina L

Mayo Clinic

Pediatric Blood & Cancer | May 10, 2023 | Volume: 70 | Issue: S4 | Pages: No page available

10.1002/pbc.30411 | PMID 37158569 Get It

AbstractPediatric cancer is a rare disease. Because of this, many sites do not have experience providing imaging for specific tumor types. The Children's Oncology Group Diagnostic Imaging Committee and the Society for Pediatric Radiology Oncology Committee are comprised of radiologists with expertise in pediatric cancer imaging. Recently, this group endeavored to create a series of 23 White Papers designed to provide evidence‐based imaging recommendations and minimum achievable imaging protocols. The purpose of this manuscript is to describe the methods employed in authoring the White Paper series.